B
DVAX

Bailard’s Dynavax Technologies DVAX Stock Holding History

Bailard’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$197K – 719
2021
Q1 		$197K Buy
+20,000
New +$165K 0.01% 670
2020
Q4 		– Sell
-268,000
Closed -$1.16M – 640
2020
Q3 		$1.16M Buy
268,000
+48,000
+22% +$342K 0.06% 187
2020
Q2 		$1.95M Buy
+220,000
New +$1.11M 0.11% 147
2019
Q2 		– Sell
-149,000
Closed -$1.09M – 559
2019
Q1 		$1.09M Buy
149,000
+51,500
+53% +$503K 0.07% 219
2018
Q4 		$892K Sell
97,500
-97,500
-50% -$1.08M 0.06% 226
2018
Q3 		$2.42M Buy
195,000
+150,000
+333% +$2.03M 0.14% 144
2018
Q2 		$686K Buy
+45,000
New +$778K 0.04% 272

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bailard's DVAX Position: Q2 2021 in Review

Bailard sold out of Dynavax Technologies (DVAX) in Q2 2021, closing a stake of 20,000 shares — an estimated $197K sold.

Bailard first reported a position in DVAX in Q2 2018 and held it in 7 quarters. The position peaked at $2.42M in Q3 2018. 154 funds tracked by Wall St. Rank hold DVAX as of Q2 2021.

  • Bailard reported no remaining Dynavax Technologies position as of Q2 2021 after selling out during the quarter.
  • Bailard sold 20,000 Dynavax Technologies shares in Q2 2021, an estimated $197K.
  • Bailard first reported a position in Dynavax Technologies in Q2 2018 and held it in 7 quarters.
  • Bailard's Dynavax Technologies position peaked at $2.42M in Q3 2018.
  • 154 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2021.

Based on Bailard's 13F filing for Q2 2021, filed 13 Aug 2021.